Goldman Sachs’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.5M | Sell |
425,994
-54,275
| -11% | -$1.97M | ﹤0.01% | 1949 |
|
|
2025
Q1 | $17.4M | Sell |
480,269
-73,401
| -13% | -$2.66M | ﹤0.01% | 1803 |
|
|
2024
Q4 | $23.3M | Buy |
553,670
+47,160
| +9% | +$1.98M | ﹤0.01% | 1665 |
|
|
2024
Q3 | $28.1M | Sell |
506,510
-123,004
| -20% | -$6.83M | ﹤0.01% | 1474 |
|
|
2024
Q2 | $25.9M | Buy |
629,514
+265,392
| +73% | +$10.9M | ﹤0.01% | 1416 |
|
|
2024
Q1 | $17M | Buy |
364,122
+209,070
| +135% | +$9.76M | ﹤0.01% | 1663 |
|
|
2023
Q4 | $7.41M | Sell |
155,052
-236,251
| -60% | -$11.3M | ﹤0.01% | 2299 |
|
|
2023
Q3 | $13.9M | Sell |
391,303
-145,425
| -27% | -$5.18M | ﹤0.01% | 1747 |
|
|
2023
Q2 | $24.8M | Buy |
536,728
+91,721
| +21% | +$4.23M | 0.01% | 1398 |
|
|
2023
Q1 | $17.8M | Sell |
445,007
-669,311
| -60% | -$26.8M | ﹤0.01% | 1601 |
|
|
2022
Q4 | $51.6M | Buy |
1,114,318
+103,130
| +10% | +$4.78M | 0.01% | 955 |
|
|
2022
Q3 | $41.9M | Buy |
1,011,188
+151,113
| +18% | +$6.26M | 0.01% | 1071 |
|
|
2022
Q2 | $51.3M | Buy |
860,075
+92,834
| +12% | +$5.54M | 0.01% | 961 |
|
|
2022
Q1 | $55.7M | Buy |
767,241
+41,563
| +6% | +$3.02M | 0.01% | 1006 |
|
|
2021
Q4 | $61M | Buy |
725,678
+219,470
| +43% | +$18.5M | 0.01% | 1002 |
|
|
2021
Q3 | $45.7M | Sell |
506,208
-136,442
| -21% | -$12.3M | 0.01% | 1148 |
|
|
2021
Q2 | $61.3M | Sell |
642,650
-115,471
| -15% | -$11M | 0.01% | 936 |
|
|
2021
Q1 | $86.3M | Sell |
758,121
-114,707
| -13% | -$13.1M | 0.02% | 665 |
|
|
2020
Q4 | $121M | Buy |
872,828
+435,332
| +100% | +$60.3M | 0.03% | 453 |
|
|
2020
Q3 | $36M | Sell |
437,496
-8,494
| -2% | -$698K | 0.01% | 1078 |
|
|
2020
Q2 | $34.9M | Sell |
445,990
-9,532
| -2% | -$746K | 0.01% | 1103 |
|
|
2020
Q1 | $20.2M | Sell |
455,522
-41,884
| -8% | -$1.86M | 0.01% | 1314 |
|
|
2019
Q4 | $21.2M | Buy |
497,406
+101,482
| +26% | +$4.33M | 0.01% | 1563 |
|
|
2019
Q3 | $16.9M | Sell |
395,924
-8,256
| -2% | -$353K | ﹤0.01% | 1629 |
|
|
2019
Q2 | $25.7M | Sell |
404,180
-91,229
| -18% | -$5.79M | 0.01% | 1423 |
|
|
2019
Q1 | $34.4M | Buy |
495,409
+194,542
| +65% | +$13.5M | 0.01% | 1254 |
|
|
2018
Q4 | $13.1M | Sell |
300,867
-3,543
| -1% | -$154K | ﹤0.01% | 1787 |
|
|
2018
Q3 | $23.2M | Buy |
304,410
+61,770
| +25% | +$4.72M | 0.01% | 1557 |
|
|
2018
Q2 | $18.7M | Sell |
242,640
-285,108
| -54% | -$21.9M | 0.01% | 1656 |
|
|
2018
Q1 | $26.9M | Buy |
527,748
+44,216
| +9% | +$2.25M | 0.01% | 1389 |
|
|
2017
Q4 | $22.4M | Sell |
483,532
-135,279
| -22% | -$6.27M | 0.01% | 1499 |
|
|
2017
Q3 | $33M | Buy |
618,811
+79,050
| +15% | +$4.21M | 0.01% | 1299 |
|
|
2017
Q2 | $33.5M | Buy |
539,761
+122,321
| +29% | +$7.6M | 0.01% | 1261 |
|
|
2017
Q1 | $28.3M | Buy |
417,440
+14,583
| +4% | +$988K | 0.01% | 1337 |
|
|
2016
Q4 | $28.3M | Sell |
402,857
-238,761
| -37% | -$16.8M | 0.01% | 1317 |
|
|
2016
Q3 | $45.5M | Buy |
641,618
+5,185
| +0.8% | +$368K | 0.01% | 1028 |
|
|
2016
Q2 | $31.1M | Buy |
636,433
+163,786
| +35% | +$8.01M | 0.01% | 1155 |
|
|
2016
Q1 | $29.9M | Buy |
472,647
+76,049
| +19% | +$4.81M | 0.01% | 1168 |
|
|
2015
Q4 | $44.5M | Sell |
396,598
-141,591
| -26% | -$15.9M | 0.01% | 961 |
|
|
2015
Q3 | $51.8M | Buy |
538,189
+343,524
| +176% | +$33.1M | 0.02% | 788 |
|
|
2015
Q2 | $19.9M | Sell |
194,665
-11,907
| -6% | -$1.22M | 0.01% | 1348 |
|
|
2015
Q1 | $12.8M | Sell |
206,572
-84,530
| -29% | -$5.25M | ﹤0.01% | 1532 |
|
|
2014
Q4 | $12.8M | Buy |
291,102
+83,029
| +40% | +$3.64M | ﹤0.01% | 1498 |
|
|
2014
Q3 | $11.8M | Buy |
208,073
+18,210
| +10% | +$1.03M | ﹤0.01% | 1529 |
|
|
2014
Q2 | $8.52M | Buy |
189,863
+64,815
| +52% | +$2.91M | ﹤0.01% | 1693 |
|
|
2014
Q1 | $6.11M | Buy |
+125,048
| New | +$6.11M | ﹤0.01% | 1842 |
|